2018 annual financial data

Ultragenyx Pharmaceutical 2018 Financial results

Direct answer

Revenue was 51,495,000 USD.

Operating income was -371,373,000 USD and net income was -197,611,000 USD.
Operating cash flow was -290,566,000 USD.

Get free Ultragenyx Pharmaceutical email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
51,495,000 USD
Operating income
-371,373,000 USD
Net income
-197,611,000 USD
Operating cash flow
-290,566,000 USD